Assertio Therapeutics (ASRT) Tops Q1 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
- BOJ eyeing September rate hike, faster pace of tightening, sources say
Assertio Therapeutics Announces First-Quarter 2019 Financial Results
May 8, 2019 4:02 PM EDT-- Reports Neurology Franchise Net Sales of $26.3 million --
-- Commercialization Agreement Revenues of $30.9 million --
-- Raises 2019 Earnings Guidance Range and Confirms Neurology Franchise Net Sales Guidance --
-- Significant Debt Reduction --
LAKE FOREST, Ill., May 08, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) today reported financial results for the quarter ended March 31, 2019, and provided an update on its business performance and strategic initiatives.
First-Quarter Financial Highlights:(unaudited)
... More